BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

348 related articles for article (PubMed ID: 30680887)

  • 21. The application of a multidisciplinary approach in the diagnosis of Castleman disease and Castleman-like lymphadenopathies: A 20-year retrospective analysis of clinical and pathological features.
    Pelliccia S; Rogges E; Cardoni A; Lopez G; Conte E; Faccini AL; De Vito R; Girardi K; Bianchi A; Annibali O; Fratoni S; Remotti D; De Angelis G; Giordano C; Palumbo G; Scarpino S; Del Porto F; Bianchi MP; Di Gregorio F; Tafuri A; Di Napoli A
    Br J Haematol; 2024 Feb; 204(2):534-547. PubMed ID: 37953489
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical, laboratory and imaging findings in Castleman's disease - The subtype decides.
    Haap M; Wiefels J; Horger M; Hoyer A; Müssig K
    Blood Rev; 2018 May; 32(3):225-234. PubMed ID: 29223447
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multicentric Castleman's disease in India - Does EBV rather than HHV8 play a role?
    Bhanvadia V; Shet T; Rao V; Epari S; Gujral S; Jain H; Bagal B; Sengar M
    Indian J Pathol Microbiol; 2021; 64(2):302-309. PubMed ID: 33851624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unicentric Castleman disease: A case report of an atypical presentation and successful management.
    Muhammad T; Alkheder A; Mazloum A; Almooay A; Naziha L; Shaheen M
    Int J Surg Case Rep; 2024 May; 118():109688. PubMed ID: 38669805
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyaline vascular variant of unicentric Castleman disease of the tonsil: a case report.
    Li P; Liu H; Li H; Li A; Yu G; Yin W
    Diagn Pathol; 2019 Jun; 14(1):70. PubMed ID: 31253137
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical spectrum of intrathoracic Castleman disease: a retrospective analysis of 48 cases in a single Chinese hospital.
    Luo JM; Li S; Huang H; Cao J; Xu K; Bi YL; Feng RE; Huang C; Qin YZ; Xu ZJ; Xiao Y
    BMC Pulm Med; 2015 Apr; 15():34. PubMed ID: 25886851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Castleman disease: Experience from a single institution.
    Abraham SS; Narayanan G; Thambi SM; Vasudevan JA; Joy Philip DS; Purushothaman PN; Nair SG; Nair R
    Med Int (Lond); 2023; 3(6):56. PubMed ID: 37927353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical and histopathology characteristics of Castleman disease: a multicenter study of 51 Brazilian patients.
    Leite JM; Barrese TZ; Sementilli L; de Freitas LLL; do Espirito Santo KS; Delamain MT; Baiocchi OCCG; Brasil SAB; Chiattone CS
    Ann Hematol; 2023 May; 102(5):1121-1129. PubMed ID: 36763110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Historical and pathological overview of Castleman disease.
    Nishimura MF; Nishimura Y; Nishikori A; Yoshino T; Sato Y
    J Clin Exp Hematop; 2022 Jun; 62(2):60-72. PubMed ID: 35474035
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasma HHV8 DNA predicts relapse in individuals with HIV-associated multicentric Castleman disease.
    Stebbing J; Adams C; Sanitt A; Mletzko S; Nelson M; Gazzard B; Newsom-Davis T; Bower M
    Blood; 2011 Jul; 118(2):271-5. PubMed ID: 21511959
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multicentric Castleman disease in an HHV8-infected child born to consanguineous parents with systematic review.
    Leroy S; Moshous D; Cassar O; Reguerre Y; Byun M; Pedergnana V; Canioni D; Gessain A; Oksenhendler E; Fieschi C; Mahlaoui N; Rivière JP; Herbigneaux RM; Muszlak M; Arnaud JP; Fischer A; Picard C; Blanche S; Plancoulaine S; Casanova JL
    Pediatrics; 2012 Jan; 129(1):e199-203. PubMed ID: 22157133
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The full spectrum of Castleman disease: 273 patients studied over 20 years.
    Oksenhendler E; Boutboul D; Fajgenbaum D; Mirouse A; Fieschi C; Malphettes M; Vercellino L; Meignin V; Gérard L; Galicier L
    Br J Haematol; 2018 Jan; 180(2):206-216. PubMed ID: 29143319
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-associated multicentric Castleman disease.
    Reddy D; Mitsuyasu R
    Curr Opin Oncol; 2011 Sep; 23(5):475-81. PubMed ID: 21760504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease.
    van Rhee F; Oksenhendler E; Srkalovic G; Voorhees P; Lim M; Dispenzieri A; Ide M; Parente S; Schey S; Streetly M; Wong R; Wu D; Maillard I; Brandstadter J; Munshi N; Bowne W; Elenitoba-Johnson KS; Fössa A; Lechowicz MJ; Chandrakasan S; Pierson SK; Greenway A; Nasta S; Yoshizaki K; Kurzrock R; Uldrick TS; Casper C; Chadburn A; Fajgenbaum DC
    Blood Adv; 2020 Dec; 4(23):6039-6050. PubMed ID: 33284946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and experimental study of Castleman disease in children.
    Zhang J; Li C; Lv L; Yang C; Kong XR; Zhu J; Zhang Y; Wang S
    Pediatr Blood Cancer; 2015 Jan; 62(1):109-14. PubMed ID: 25213773
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human herpesvirus 8-positive multicentric Castleman disease with germinotropic plasmablastic aggregates: Overlapping spectrum of human herpesvirus 8-associated lymphoproliferative disorder.
    Nakaya Y; Ishii N; Kasamatsu Y; Shimizu K; Tatsumi N; Tsutsumi M; Yoshida M; Yoshimura T; Hayashi Y; Nakao T; Inoue T; Yamane T
    Pathol Int; 2020 Aug; 70(8):574-580. PubMed ID: 32449234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective cohort evaluation of non-HIV Castleman disease from a single academic center in Beijing, China.
    Guo M; Nong L; Wang M; Zhang Y; Wang L; Sun Y; Wang Q; Liu H; Ou J; Cen X; Ren H; Dong Y
    Ann Hematol; 2024 Jan; 103(1):153-162. PubMed ID: 37749319
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A national, multicenter, retrospective study of Castleman disease in China implementing CDCN criteria.
    Zhang L; Dong YJ; Peng HL; Li H; Zhang MZ; Wang HH; Liu QH; Su LP; Zhong LY; Wu WJ; Huang L; Yan XJ; Fan L; Tang WJ; Li ZL; Bi LT; Li Y; Gao GX; Gao L; Liu TB; Wei YQ; Liu Y; Yu L; Zhou H; Sun CY; Qian WB; Zou DH; Zhang HL; Ding KY; Wang XB; Bai O; Huang WR; Chen B; Yang L; Song J; Gao D; Chen T; Luo J; Wang SY; Ma LM; Fajgenbaum DC; Li J;
    Lancet Reg Health West Pac; 2023 May; 34():100720. PubMed ID: 37283978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical dissection of multicentric Castleman disease.
    Shin DY; Jeon YK; Hong YS; Kim TM; Lee SH; Kim DW; Kim I; Yoon SS; Heo DS; Park S; Kim BK
    Leuk Lymphoma; 2011 Aug; 52(8):1517-22. PubMed ID: 21585280
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis of the clinicopathologic features as well as diagnosis and treatment of 59 patients with Castleman disease].
    Wang J; Liang LJ; Wang YM; Mei ZY; Liu YZ; Liu LN; Fang BJ; Song YP
    Zhonghua Xue Ye Xue Za Zhi; 2020 Aug; 41(8):666-670. PubMed ID: 32942821
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.